Synonyms: AR 12286 | AR-12286
Compound class:
Synthetic organic
Comment: Verosudil is an investigational Rho kinase inhibitor.
The INN record for verosudil indicates that this is a racemic mixture. We show the chemical structure without stereochemistry to represent the mixture. The (2S)-isomer is represented in PubChem CID 86270580 and the (2R)-isomer is represented in CID 44198631. |
|
No information available. |
Summary of Clinical Use ![]() |
Verosudil is being evaluated in Phase 2 clinical trial for its potential to reduce intraocular pressure in patients diagnosed with ocular hypertension or glaucoma [1]. Click here to link to ClinicalTrials.gov's listing of AR-12286 trials. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
Non-human primate studies suggest that AR-12286 lowers intraocular pressure primarily by increasing aqueous humor outflow through the trabecular meshwork, as do other Rho kinase inhibitors such as fasudil and Y27632. |